AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05278676 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dotinurad
Description: Dotinurad oral tablet.
Study NCT05560178 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SEXUAL HEALTH EDUCATION
Description: Women in the intervention group will be given sexual health education once a week for 4 weeks
Study NCT05942729 — intervention group
Intervention type: OTHER
Intervention: Determine the etiology of hypokinetic and hypertrophic heart disease on transthoracic echocardiography data alone
Description: The origin of the pathology will have been previously diagnosed for each patient thanks to complementary examinations performed as part of routine care (e.g. cardiac CT, cardiac MRI, coronary angiography, thorough biology, nuclear medicine). This information will be used (i) to guide the learning of the AI method developed during the project from a sub-population (80% of the collected database will be used to train the algorithms); (ii) to serve as an evaluation criterion from a test sub-population (remaining 20% of the collected database)
Study NCT06077110 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: P-OMICs-flow services
Description: The Service Intervention is the P-OMICs-flow clinic being delivered at The Prince of Wales Hospital. This clinic provides a streamlined, multidisciplinary model to seamlessly integrate research-led precision medicine into the routine oncology setting.
Study NCT05514145 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nance/Transpalatal arch space maintainer
Description: A combined design of both Nance and Transpalatal arch space maintainers as a space maintainer for the maxillary arch in mixed dentition
Study NCT05514145 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nance space maintainer
Description: Conventional space maintainer for the maxillary arch used in mixed dentition
Study NCT06016140 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medication plan
Description: Involved participants will jointly agreed on continued medication treatment (treatment aim, planned monitring and evaluation and responsibility, and the physician will document the plan in the electronic health record
Study NCT06066957 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letermovir 480 MG [Prevymis]
Description: Letermovir for CMV prophylaxis in thoracic organ transplant recipients.~Letermovir will be administered by oral administration, as per study protocol. The intended duration of therapy will be up to 365 days, depending on organ transplanted and donor and recipient CMV status. However, treatment may discontinued as discussed in Section 7.~Letermovir is dosed at 480mg daily for patients with CrCl >10. Dose adjustment, as per package insert, is recommended in setting of co-administration of cyclosporine, with dose reduction of letermovir to 240mg daily. Missed doses of letermovir will not be made up.
Study NCT06086756 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure intervention plus positive mood induction
Description: Positive mood induction followed by a brief VR exposure session for public speaking anxiety.
Study NCT06086756 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure intervention plus negative mood induction
Description: Negative mood induction followed by a brief VR exposure session for public speaking anxiety.
Study NCT05570799 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Augmented Reality and Kahoot game learning
Description: * An augmented reality (AR) mobile application with image based will be used by the participants in the experimental group.~* Also, students will participate in Kahoot game. Students will participate in the game using their own devices by going to https://kahoot on their phones and entering their password and password.
Study NCT04383314 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 10-week exercise program on HA accumulation
Description: A 10-week exercise program with both aerobic and resistance components, based on the American College of Sports Medicine (2010), will be individually prescribed to 25 T2DM patients.Exercise training will be performed on Days 1 and 2 of each week under the supervision of licensed physical therapists. Participants will have the choice of using a treadmill or a recumbent stepper. The physical therapists will monitor blood glucose level, blood pressure, heart rate, and RPE during each exercise session. Participants will be asked to exercise at home on Day 3 of each week, and will not be supervised by the study team.
Study NCT05898750 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: MorDom
Description: oral powder in tea bags contains 4gm twice daily (equal concentration of each drugs)
Study NCT04911699 — intervention group
Intervention type: BEHAVIORAL
Intervention: breast adenocarcinoma receiving chemotherapy
Description: for chemotherapy
Study NCT04846387 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Post-Void Residual
Description: The patient's post-void residual is determined using a portable ultrasound machine after emptying the bladder just prior to entering the MRI scanner and immediately after the MRI scan.
Study NCT04911699 — intervention group
Intervention type: BEHAVIORAL
Intervention: Control-for
Description: hormonal drug treatment
Study NCT05605977 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Traditional visual-motor training program
Description: Traditional visual-motor program includes play and paper-and-pencil activities
Study NCT05605977 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Computerized visual-motor training program
Description: Computerized visual-motor training program includes tablet visual-motor games
Study NCT04552717 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: My Grief
Description: The app will build on principles of cognitive behavioural theory and therapy (CBT) and contains four main sections: Learning, Self-assessment, Manage symptoms and Find support.
Study NCT05496218 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Blood samples
Description: At study entry, we will collect morning blood samples from fasting women. participants will be asked with an interview on demographic and lifestyle characteristics, health-related behaviours, the existence and duration of infertility, medical history, and history of hormonal or surgical treatments for endometriosis. Pain symptoms before surgery will be evaluated through a 10 cm long one-dimensional visual-analogue scale (VAS). In addition, women will be asked to report about their usual weekly food consumption in the previous year. Information on the diet will be based on a reproducible and valid food frequency questionnaire. Energy and mineral and macro-and micronutrient intakes will be estimated using the most recent update of an Italian Food Consumption Database.
Study NCT05321095 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Albuminuria test
Description: During participation, subjects are asked to collect one or more urine samples for albuminuria determination.
Study NCT05321095 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: HbA1c test
Description: During the screening visit, HbA1c will be measured with a point-of-care test (Affinion HbA1c, Abbott).
Study NCT05321095 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Creatinine test
Description: During the screening visit, creatinine will be measured with a point-of-care test (i-STAT Alinity handheld analyser, Abbott).
Study NCT04846387 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Uroflowmetry
Description: Patients will urinate into a funnel connected to an electric flow meter to record urine flow rates in mililters per second. This is used as part of the screening process.
Study NCT05000463 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ozone
Description: The participants will lay flat and the area of injection will be prepared with antiseptic. Maintenance of ultrasonography probe sterility was also guaranteed using a sterile barrier. Under sonographic guidance, superficial peroneal nerve, deep peroneal, sural , asphenous, and tibila nerves will be injected An ozone/oxygen mixture ( 25μg/ml) will be injected in each nerev
Study NCT05000463 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Convtrol group
Description: The medical treatment included optimal glycemic control, vitamin B complex, a lipoic acid, selective serotonin reuptake inhibitors, and pregabalin.
Study NCT05953311 — intervention group
Intervention type: OTHER
Intervention: Blood analysis
Description: Blood analysis for neurological biomarkers measurements
Study NCT05953311 — intervention group
Intervention type: OTHER
Intervention: Cognitive tests
Description: Questionnaires assessing cognitive function
Study NCT04846387 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionaire - AUA Symptom Score
Description: Subjects will fill out questionnaire asking about urinary symptoms. The range is 0-35.
Study NCT04997434 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Art-therapy in the emergency department
Description: The intervention will begin with a 5-10 minute interview with the patient to define his or her tastes and contraindications to certain techniques. Since the art-therapeutic intervention that will be proposed seeks to generate pleasant feelings, it will be important to rely on the patient's tastes. At the end of the interview, modern art therapy will be presented to the patient and several artistic activities will be proposed (origami, drawing, creative writing).~Once the activity has been chosen, the patient will have 15 to 20 minutes to carry it out, accompanied by the art therapist according to his/her needs. During the activity, verbal exchanges will continue. After the 15 to 20 minutes of the session, 5 minutes will be devoted to the patient's self-evaluation of the past moment, of his level of anxiety, of the intensity of his pain and of his feelings in relation to his passage in the Emergency Department and the art therapy session.
Study NCT05855681 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: therapeutic exercises
Description: strengthening exercise and stretching exercise
Study NCT01087138 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise
Description: exercise class 3x's/week
Study NCT01087138 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise and calcium
Description: exercise class 3x's/week and 1500mg calcium intake
Study NCT06043531 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental: EVOO
Description: Subjects will consume 50g of cold pressed EVOO per day for 28 days.
Study NCT05855681 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: therapeutic exercises
Description: strengthening exercise and stretching exercise
Study NCT05494983 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Screening visit
Description: The participants will be screened for inclusion and exclusion criteria and will be asked to fill the following questionnaires : Pittsburgh Sleep Quality Index, State and Trait Anxiety Questionnaire, Pain Catastrophizing Scale Fear of Pain Questionnaire, Perceived Stress Scale, Beck Depression Inventory, and questionnaires to assess their health status and the use of medications. A blood sample (to measure pro- and anti-inflammatory cytokines and perform metabolomic analyses) will be obtained. Enrolled participants will be given a wearable actimeter to assess daily total sleep duration during one week before the first experimental session. They will also be requested to complete daily a sleep diary during one week before each experimental session, and a food diary before the first experimental session. A fecal sample (to assess gut microbiota composition and perform metabolomic analyses) will be collected between the screening visit and the first experimental session.
Study NCT05494983 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Peripheral sensitization session
Description: The extent of neurogenic inflammation induced by topical capsaicin will be used as a measure of the susceptibility to sensitize at peripheral level. A solution of capsaicin will be applied to the skin of the left or right volar forearm for 30 minutes. The capsaicin-induced neurogenic inflammation can be quantified by assessing the intensity, extent and duration of the capsaicin-induced cutaneous flare response using thermal infrared imaging. Using heat stimuli delivered to the treated skin and surrounding skin, the intensity and duration of the capsaicin-induced hyperalgesia will also be assessed. The experimental session will last approximately two hours.
Study NCT05494983 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Central sensitization session
Description: The extent of secondary mechanical hyperalgesia induced by high-frequency electrical stimulation (HFS) of the skin of the left or right volar forearm will be used as a measure of the susceptibility to develop central sensitization. The stimulation will be delivered using a multi-pin electrode designed to preferentially activate epidermal free nerve endings. The strength, spatial extent and duration of the HFS-induced changes in pinprick sensitivity will be characterized by using calibrated mechanical pinprick stimuli. The experimental session will last approximately one hour.
Study NCT04353310 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Curcumin
Description: Curcumin 1500mg PO BID
Study NCT05997186 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Surgical reconstruction
Description: Surgical reconstruction with a free reinnervated profunda artery perforator flap
Study NCT06295601 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional rehabilitation
Description: The program consists of a joint treatment in which lower extremity strengthening and balance exercises are carried out synchronously. The program will include a total of 5 minutes of warm-up, 5 minutes of cool-down and 30 minutes of exercises related to the program. The difficulty of the program will increase by changing the number of exercises and increasing the weight in strengthening exercises. Progress in balance and coordination exercises will vary by changing the ground, increasing the standing time, and keeping the eyes open and closed.
Study NCT06295601 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Action observation therapy and motor imagery
Description: In the experimental group, in addition to traditional telerehabilitation, action observation and motor imagery of 4 exercises will be performed in each session. A video will be prepared for 4 exercises. Then, the participant will perform 2 minutes of action observation of each movement, followed by 1 minute of motor imagery. In addition to the traditional telerehabilitation program, a 12-minute combination of action observation and motor imagery will be performed in each session. Exercises will be changed every two weeks, gradually increasing the difficulty.
Study NCT06138327 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMN 255
Description: Oral Capsule
Study NCT06138327 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral Capsule
Study NCT04949945 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self Help Culturally Cognitive Behavioral Therapy
Description: Experimental group (CHF patients)will be screened on PHQ9 questionnaire for depression after receiving guided self help culturally adapted cognitive therapy they will be reassessed for their depression,improvement in functional disability ,improvement in classification of NYHA,reduction in hospital admission as compare to control group.
Study NCT05799391 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SJC
Description: Soothing cream jel
Study NCT05799391 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo cream jel
Study NCT05978336 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Coaching Program
Description: The HC program will be delivered over 26-weeks. Participants will have an initial hour-long HC session where the BAP coach will conduct a brief physical assessment and work with the participant to establish their physical activity goals and develop a plan. After the initial consult, coaches will conduct 8 x 20-minute phone calls with participants over the 26-week trial decreasing from bi-weekly phone calls in weeks 1-12 to monthly phone calls in weeks 13-26.~Participants in the HC group will have an overall goal of increasing their weekly participation in moderate to vigorous physical activity by 50 minutes, via 5-, 7-, or 10-minute bouts of progressive exercises, at a rate of perceived exertion range of 13-14 (somewhat hard) by week 16. Participants will have access to specific exercise sessions made available by YouTube and/or hardcopy manuals created by the research team.
Study NCT05978336 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Education Program
Description: Participants will begin with a one-hour, group-based, interactive education session on falls prevention delivered either in-person or by Zoom. Following the initial education session, ED participants will receive additional group education sessions (in-person or by Zoom) with the same duration and schedule as the HC program covering a variety of healthy aging topics.
Study NCT06299592 — intervention group
Intervention type: COMBINATION_PRODUCT
Intervention: PET/MRI using [18F]FEPPA tracer
Description: PET/MRI scans with \[18F\]FEPPA radiotracer selective for translocator protein (TSPO) binding, which is elevated in activated microglia
Study NCT05731271 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TST003
Description: IV humanized anti-GREM1 monoclonal antibody
Study NCT00545207 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ibandronate [Bonviva/Boniva]
Description: 150mg po monthly for 2 years
Study NCT00545207 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: po monthly for 2 years
Study NCT06229587 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: furlow with buccinator flap
Description: Assessment of speech and the middle ear function of patients between the age of 3 and 7 years surgically treated by ARC (Furlow z-palatoplasty with a buccinator myomucosal flap) was done
Study NCT04353310 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: identical in appearance to curcumin
Study NCT05091411 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant new coronavirus vaccine (CHO cell) group
Description: Intramuscular injection of deltoid muscle of upper arm of 25μg/0.5ml/person doseRecombinant new coronavirus vaccine (CHO cells).
Study NCT06316726 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: full bed silicone mattress plus other measures
Description: full bed silicone mattress plus put silicone pads on the head and shoulders, cotton rolls wraps bony prominence (elbows and heels), petrissage every two hours on shoulders to fingers and lower legs to heels, change location of ankle pads, use round gel full of air sit pad, a pillow on the knees
Study NCT04973358 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: buccotherm mouthwash
Description: twice a day for 14 weeks
Study NCT04973358 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo mouthwash
Description: twice a day for 14 weeks
Study NCT04528030 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: WAVE device
Description: WAVE applies a transcutaneous vibration to the soles of the foot and palms of the hand to elicit nerve signalling from pressure and other limb proprioceptor sensors to pontine, cerebellar, and medullary brain areas that coordinate limb movement and reflexively activate brain areas controlling breathing. The WAVE device is a battery-operated product to reduce the episodes of Apnoea of Prematurity by vibratory stimulation to the hand and foot.
Study NCT06198036 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hold-Relax Technique
Description: Participants in this group will be treated with hold-relax PNF Technique
Study NCT06198036 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Muscle Energy Technique
Description: Participants in this group will be treated with Muscle Energy Technique via Reciprocal Inhibition Mechanism
Study NCT05102136 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN9933
Description: Administered intravenously (IV) or subcutaneous (SC) per the protocol
Study NCT04618926 — intervention group
Intervention type: DEVICE
Intervention: Device intubating Laryngeal Tube Suction Disposable
Description: Resuscitation in covid 19 patients
Study NCT05909137 — intervention group
Intervention type: RADIATION
Intervention: IMRT+adjuvant immunotherapy
Description: The enrollment was randomly (1:1) assigned into the study group with CTV-omitted IMRT and the control group with CTV-delineated IMRT using a random number table.
Study NCT05102136 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo to match REGN9933 in same form; placebo administered IV or SC per the protocol
Study NCT05719207 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Balloon dilation of eustachian tube (Stryker XprESS LoProfile ENT dilation system)
Description: Patients in the intervention group would undergo balloon dilation of the eustachian tube under local anesthetic in clinic. The Stryker XprESS LoProfile ENT dilation system will be used. Participants may undergo dilation under general anesthesia if a contraindication to in-clinic dilation exists.
Study NCT05719207 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham procedure
Description: Patients in the sham group will undergo the motions of an in-office dilation of the eustachian tube, without actually dilating the eustachian tube.